Many Black and Latino families are navigating Alzheimer’s without access to the information, resources, and community support ...

NHS watchdog to review evidence on two pioneering Alzheimer’s drugs - Donanemab and lecanemab were licensed for use in the UK in 2024 but were not made available on the NHS after Nice deemed their ben ...

A study in the journal Neurology has shown that people with type 1 diabetes are three times more likely to develop dementia ...

New analyses show DLB patients with lower plasma pTau181 levels - indicating an earlier stage of disease and absence of ...

Alzheimer’s disease is devastating to families and many of those patients also suffer from heart problems. Pioneering MUSC research show the same toxic proteins cause both, with potential for therapy.

Smith Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory ...

A new Duke study is exploring whether cells inside the nose could reveal early signs of Alzheimer’s disease. Researchers say ...

Most people think of brushing and flossing as a way to keep their teeth looking good. But emerging research suggests that ...

Alzheimer's disease is the most common cause of dementia, and it affects over 7 million people in the United States alone.

People carrying at least one APOE4 allele have a higher risk of Alzheimer's disease compared with APOE3/3 carriers; people with two APOE4 alleles have the highest risk. The APOE2 allele is associated ...

New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University ...

Frontotemporal dementia (FTD), in particular, may be at play, and identifying ways to slow down its progression can help. In ...